Naftifine Topical Dosage

This dosage information may not include all the information needed to use Naftifine Topical safely and effectively. See additional information for Naftifine Topical.

The information at Drugs.com is not a substitute for medical advice. ALWAYS consult your doctor or pharmacist.

Usual Adult Dose for:

Additional dosage information:

Usual Adult Dose for Tinea Corporis

2% Cream: A thin layer should be applied to the affected areas plus a 1/2 inch margin of healthy surrounding skin once a day for 2 weeks.

1% Cream: A sufficient quantity should be gently massaged into the affected and surrounding skin areas once a day.

1% Gel: A sufficient quantity should be gently massaged into the affected and surrounding skin areas twice a day in the morning and evening.

Usual Adult Dose for Tinea Cruris

2% Cream: A thin layer should be applied to the affected areas plus a 1/2 inch margin of healthy surrounding skin once a day for 2 weeks.

1% Cream: A sufficient quantity should be gently massaged into the affected and surrounding skin areas once a day.

1% Gel: A sufficient quantity should be gently massaged into the affected and surrounding skin areas twice a day in the morning and evening.

Usual Adult Dose for Tinea Pedis

2% Cream: A thin layer should be applied to the affected areas plus a 1/2 inch margin of healthy surrounding skin once a day for 2 weeks.

1% Cream: A sufficient quantity should be gently massaged into the affected and surrounding skin areas once a day.

1% Gel: A sufficient quantity should be gently massaged into the affected and surrounding skin areas twice a day in the morning and evening.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

If irritation or sensitivity develops with use, therapy should be discontinued and appropriate treatment instituted. Patients should be advised to contact their physician if such conditions develop after use of naftifine topical.

The patient should be reevaluated if no clinical improvement is seen after 4 weeks of therapy with the 1% formulations.

Safety and effectiveness have not been established in pediatric patients (less than 18 years of age).

Dialysis

Data not available

Other Comments

The hands should be washed after application.

Naftifine topical is only intended for topical use (not for ophthalmic, oral, or intravaginal use). Patients should be advised to keep naftifine topical away from the eyes, nose, mouth, and other mucous membranes.

Diagnosis of the disease should be confirmed by direct microscopic examination or by culture.

Hide
(web5)